BOT:ASX
Botanix Pharmaceuticals Ltd
0,010 AUD
0,00%
(0,00) 1D
19 ნოე, 10:27:16 GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BOT...
Open
0,01 AUD
High
0,01 AUD
Low
0,01 AUD
Mkt. cap
27,63 მლნ.
Avg. vol.
11,81 მლნ.
Volume
523,06 ათ.
52-wk high
0,15 AUD
52-wk low
0,01 AUD
EPS
-0,03 AUD
Shares outstanding
2,76 მლრდ.
No. of employees
11
Open
0,01 AUD
High
0,01 AUD
Low
0,01 AUD
Mkt. cap
27,63 მლნ.
Avg. vol.
11,81 მლნ.
Volume
523,06 ათ.
52-wk high
0,15 AUD
52-wk low
0,01 AUD
EPS
-0,03 AUD
Shares outstanding
2,76 მლრდ.
No. of employees
11
News stories
From web sources and news partners
The Motley Fool
·
1 საათის წინ
Stock Market Today, Nov. 18: S&P 500 Breaks Key Support as Fed Minutes Signal More Rate Hikes Ahead
RealMoney Pro
·
1 საათის წინ
A Concerning Nvidia Reversal Pulls the S&P 500 to a Fifth Down Day
FXStreet
·
1 საათის წინ
Dow Jones Industrial Average drops as UnitedHealth and Nvidia fall
Traders Union
·
2 საათის წინ
Peter Tuchman: S&P 500 loses $2.5 trillion in market cap over five days
Profile
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company's lead product is Sofdra, which treats axillary hyperhidrosis. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
About Botanix Pharmaceuticals Ltd
CEO-
Employees11
Founded1984
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websitebotanixpharma.com